Klara Dickinson-Eason
Geen lopende functies
Loopbaan van Klara Dickinson-Eason
Eerdere bekende functies van Klara Dickinson-Eason
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| CYMABAY THERAPEUTICS, INC. | Compliance Officer | 01-01-2019 | - |
| General Counsel | 26-06-2017 | 22-03-2024 | |
| ANTHERA PHARMACEUTICALS, INC. | General Counsel | 05-01-2015 | 20-06-2017 |
| HYPERION THERAPEUTICS INC | Compliance Officer | 24-07-2012 | 26-02-2014 |
| General Counsel | 04-10-2007 | 08-07-2014 | |
CoTherix, Inc.
 CoTherix, Inc. Pharmaceuticals: MajorHealth Technology CoTherix, Inc. develops therapeutic products. Its ventavis product is a nebulizer delivered therapy for pulmonary artery hypertension, which restricts blood flow to the lungs. CoTherix markets its products in the US, Europe, and Australia. The company was founded in February, 2000 by Donald J. Santel and Gerard Turino and is located in Brisbane, CA. | Compliance Officer | 01-01-2004 | 04-10-2007 |
| General Counsel | 01-01-2004 | 04-10-2007 | |
| Dey Laboratories, Inc. | General Counsel | 01-01-1993 | - |
Scios, Inc.
 Scios, Inc. Pharmaceuticals: MajorHealth Technology Scios Inc. developed, manufactured, and commercialized pharmaceuticals for conditions such as cardiovascular and inflammatory diseases. The company was founded in 1981 and was headquartered in Sunnyvale, CA. | Corporate Officer/Principal | - | - |
Opleiding van Klara Dickinson-Eason
| Great Falls College MSU | Undergraduate Degree |
Statistieken
Internationaal
| Verenigde Staten | 8 |
Operationeel
| General Counsel | 5 |
| Compliance Officer | 3 |
| Corporate Officer/Principal | 1 |
Sectoraal
| Health Technology | 6 |
| Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| ANTHERA PHARMACEUTICALS, INC. | Health Technology |
| Bedrijven in privébezit | 5 |
|---|---|
Scios, Inc.
Scios, Inc. Pharmaceuticals: MajorHealth Technology Scios Inc. developed, manufactured, and commercialized pharmaceuticals for conditions such as cardiovascular and inflammatory diseases. The company was founded in 1981 and was headquartered in Sunnyvale, CA. | Health Technology |
CymaBay Therapeutics, Inc.
 CymaBay Therapeutics, Inc. BiotechnologyHealth Technology CymaBay Therapeutics, Inc. engages in the provision and development of access to therapies for patients with liver and other chronic diseases with high unmet medical needs. Its products pipeline includes Seladelpar, MBX-2982, CB-0406, and CB-001. The company was founded on October 5, 1988 and is headquartered in Newark, CA. | Health Technology |
CoTherix, Inc.
CoTherix, Inc. Pharmaceuticals: MajorHealth Technology CoTherix, Inc. develops therapeutic products. Its ventavis product is a nebulizer delivered therapy for pulmonary artery hypertension, which restricts blood flow to the lungs. CoTherix markets its products in the US, Europe, and Australia. The company was founded in February, 2000 by Donald J. Santel and Gerard Turino and is located in Brisbane, CA. | Health Technology |
Hyperion Therapeutics, Inc.
 Hyperion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Hyperion Therapeutics, Inc. developed and commercialized pharmaceutical products. The company was founded by Mark Blumling and Christopher Eugene Rivera on November 1, 2006 and headquartered in Brisbane, CA. | Health Technology |
| Dey Laboratories, Inc. |
